follow
anthrax
attack
recent
sar
outbreak
concern
emerg
reemerg
infecti
diseas
catalyz
renew
interest
develop
new
vaccin
strategi
provid
rapid
flexibl
respons
option
futur
threat
probabl
encount
one
exot
agent
unknown
essenti
new
vaccin
formul
employ
method
provid
effect
protect
extrem
good
safeti
profil
use
either
militari
civilian
popul
one
approach
potenti
satisfi
criteria
use
live
recombin
gramposit
commens
bacteria
express
vector
review
provid
overview
system
advantag
limit
detail
exampl
gramposit
commens
bacteria
develop
fifth
gener
vaccin
class
biowarfar
pathogen
name
smallpox
one
major
biomed
concern
continu
emerg
new
infecti
agent
caus
diseas
human
popul
recent
year
provid
number
exampl
includ
hiv
west
nile
viru
sar
increas
frequenc
antibioticresist
bacteri
isol
although
natur
respons
problem
equal
great
concern
possibl
infecti
agent
introduc
environ
deliber
act
bioterror
biowarfar
biowarfar
concern
use
limit
battlefield
interact
arm
combat
howev
readi
access
modern
molecular
biolog
microbiolog
procedur
rel
easi
person
obtain
grow
dispers
biowarfar
agent
express
purpos
caus
morbid
mortal
target
popul
chemic
toxin
bona
fide
threat
infecti
pathogen
repres
biggest
problem
sever
reason
first
wide
divers
pathogen
agent
bacteria
virus
fungi
etc
capabl
caus
varieti
diseas
second
unlik
chemic
toxin
microorgan
abil
replic
surviv
environ
third
case
microorgan
abil
spread
individu
individu
weapon
like
deploy
recal
control
distinguish
friend
foe
list
viral
bacteri
pathogen
rate
accord
predict
risk
nation
secur
compil
center
diseas
control
prevent
tabl
categori
agent
pose
seriou
threat
easili
dissemin
spread
person
person
result
high
mortal
rate
may
caus
public
panic
would
requir
special
action
public
health
prepared
pathogen
categori
b
second
prioriti
moder
eas
dissemin
moder
morbid
low
mortal
rate
addit
cdc
diagnost
capac
diseas
surveil
capabl
agent
current
inadequ
would
requir
vast
improv
agent
compris
categori
c
includ
could
easili
engin
mass
dissemin
futur
avail
potenti
easili
produc
dissemin
pathogen
list
tabl
caus
smallpox
anthrax
plagu
particularli
danger
easili
spread
person
person
via
respiratori
rout
accident
plan
natur
outbreak
one
agent
respiratori
mode
transmiss
combin
frequent
worldwid
travel
preval
today
societi
could
lead
disastr
consequ
potenti
occur
evid
recent
sar
outbreak
coronaviru
respons
caus
sar
virul
easili
transmit
outcom
last
year
outbreak
could
devast
addit
introduct
natur
pathogen
human
popul
bioterrorist
capabl
exist
pathogen
purpos
engin
becom
even
infecti
eas
pathogen
may
made
virul
demonstr
experi
perform
jackson
et
al
experi
immunesuppress
gene
splice
mousepox
viru
creat
viru
caus
signific
mortal
even
immun
mice
order
effect
protect
popul
infecti
biowarfar
threat
number
measur
need
deploy
detect
surveil
develop
method
monitor
environment
space
detect
unusu
unexpect
infecti
agent
arriv
diagnost
rapid
method
determin
type
pathogen
arriv
toxin
bacteria
viru
perhap
profil
genom
drug
resist
treatment
develop
drug
therapeut
treat
individu
expos
expos
firstrespond
militari
personnel
nontradit
pathogen
agent
decontamin
neutral
andor
remov
environ
introduc
shed
infect
individu
epidemiolog
identifi
individu
risk
final
prophylaxi
develop
deploy
effect
safe
vaccin
either
break
epidem
prevent
primari
infect
fig
measur
import
overal
biodefens
scheme
develop
new
gener
vaccin
focu
subsequ
discuss
vaccin
wide
consid
one
miracl
modern
medicin
widespread
implement
greatli
reduc
diseas
burden
common
diseas
pertussi
measl
case
smallpox
complet
elimin
diseas
human
popul
histor
four
gener
vaccin
exampl
regard
viral
vaccin
first
gener
repres
live
virus
vaccinia
viru
rabi
viru
grown
anim
harvest
chemic
inactiv
case
rabi
viru
second
gener
vaccin
grown
embryon
chicken
egg
typifi
tradit
influenza
vaccin
advent
cell
cultur
technolog
herald
third
gener
vaccin
measl
mump
grown
tissu
cultur
cell
fourth
gener
vaccin
current
stateoftheart
typifi
hepat
b
vaccin
compon
viru
clone
overexpress
purifi
recombin
microorgan
deliv
subunit
vaccin
combin
adjuv
uniqu
challeng
associ
develop
vaccin
biowarfar
agent
make
tradit
vaccin
develop
approach
difficult
mani
case
pauciti
research
data
avail
replic
virul
mechan
exot
pathogen
likewis
case
smallpox
appropri
anim
model
conduct
challeng
experi
moreov
sinc
mani
diseas
agent
interest
caus
death
test
human
directli
vaccin
develop
biowarfar
agent
repres
conundrum
one
hand
diseas
question
high
associ
morbid
mortal
yet
hand
likelihood
encount
pathogen
extrem
low
sinc
vaccin
side
effect
associ
one
need
care
consid
risktobenefit
ratio
type
product
order
vaccin
biowarfar
agent
wide
implement
shown
effect
anim
model
extrem
safe
unlik
tradit
vaccin
approach
meet
requir
therefor
fifth
gener
vaccin
deliveri
technolog
need
employ
number
new
vaccin
deliveri
technolog
develop
show
promis
includ
dna
vaccin
transderm
patch
recombin
plant
use
commens
bacteria
antigen
deliveri
platform
hold
particular
promis
util
commens
bacteria
found
natur
flora
live
organ
bacteria
resid
mainli
within
mucos
site
mouth
nose
lung
gastrointestin
urogenit
tract
although
normal
toler
commens
organ
mucos
surfac
present
physic
barrier
invad
pathogen
also
provid
primari
line
defens
possess
specif
local
immun
system
provid
import
compon
protect
immun
antigen
deliveri
directli
mucos
site
via
nonpathogen
commens
bacteri
vector
could
provid
signific
advantag
tradit
vaccin
live
bacteria
capabl
stimul
sustain
system
well
local
immun
respons
addit
commens
bacteria
abl
colon
nich
invad
pathogen
stimul
immun
respons
portal
entri
prevent
infect
abil
combin
fact
bacteria
easili
administ
ie
topic
cost
effici
welltoler
make
live
commens
bacteria
attract
vehicl
subunit
vaccin
deliveri
one
promis
commens
bacterium
streptococcu
gordonii
normal
inhabit
human
oral
caviti
secret
protein
express
spex
bacteri
commens
vector
bcv
system
novel
protein
express
vector
system
use
gordonii
produc
export
protein
fig
system
use
conserv
pathway
gramposit
bacteria
util
export
anchor
protein
cell
surfac
foreign
protein
direct
cell
surfac
gramposit
host
use
portion
protein
surfac
protein
pyogen
fusion
partner
ctermin
end
protein
consist
conserv
immunogen
crepeat
region
crr
hydrophil
region
highli
conserv
enzymat
cleavag
site
progli
hydrophob
amino
acid
act
anchor
protein
cell
surfac
fig
secret
protein
need
stop
codon
introduc
carboxi
terminu
foreign
protein
without
membraneanchor
region
retain
protein
surfac
gordonii
fusion
protein
transloc
cell
membran
gramposit
host
cell
secret
directli
cultur
medium
fig
call
spex
vector
system
secret
protein
express
candid
antigen
identifi
rel
easi
task
creat
commens
bcv
recombin
express
restrict
site
incorpor
primer
homolog
dna
sequenc
interest
gene
synthes
pcr
dna
fragment
clone
plasmid
plasmid
replic
gramposit
host
must
integr
chromosom
natur
compet
gordonii
order
impart
erythromycin
resist
integr
correct
chromosom
locat
confirm
pcr
express
encod
antigen
test
western
blot
use
appropri
antisera
encod
antigen
exist
mprotein
fusion
specif
antiserum
avail
antigen
express
heterolog
protein
test
reactiv
antim
protein
monoclon
antibodi
number
differ
promot
element
insert
site
enabl
express
multipl
foreign
insert
recombin
identifi
gordonii
could
potenti
allow
simultan
present
two
antigen
singl
bacterium
addit
insert
site
contain
induc
promot
character
therebi
allow
control
express
heterolog
gene
final
possibl
express
antigen
chromosom
plasmid
plasmidbas
system
easili
adapt
express
gramposit
speci
lactococcu
lacti
exampl
success
express
portion
pyogen
protein
surfac
l
lacti
plasmid
hrubi
unpublish
protein
viru
bacteria
protozoan
anim
human
success
express
use
gordonii
heterolog
protein
express
bcvspex
system
shown
reactiv
appropri
antisera
impress
list
limit
use
bacteria
express
eukaryot
protein
bacteria
abl
perform
posttransl
process
ie
disulfid
bond
glycosyl
myristoyl
etc
import
structur
function
mani
eukaryot
protein
henc
antibodi
specif
includ
recognit
modifi
protein
gener
respons
bcv
bacteri
express
vector
altern
mode
antigen
deliveri
would
need
explor
gordonii
readili
colon
mice
rat
monkey
well
human
henc
abil
recombin
bcv
induc
immun
respons
examin
sever
anim
model
first
demonstr
gordonii
could
success
induc
mucos
system
immun
respons
foreign
antigen
present
experi
perform
medaglini
et
al
express
hornet
venom
allergen
fusion
protein
anchor
region
protein
pyogen
induc
signific
increas
salivari
lung
iga
well
increas
system
igg
mice
sever
addit
studi
shown
varieti
antigen
express
surfac
gordonii
immunogen
deliv
mice
monkey
either
system
mucos
rout
immun
rabbit
live
heatkil
gordonii
express
domain
porphyromona
gingivali
fimbrillin
protein
bordetella
pertussi
toxin
induc
antibodi
specif
encod
antigen
addit
induc
potent
humor
immun
respons
recombin
gordonii
intern
human
mous
dendrit
cell
encod
antigen
present
mhc
class
ii
molecul
well
mhc
class
molecul
importantli
potenti
recombin
gordonii
develop
safe
vaccin
vector
support
find
immun
mice
gordonii
express
tetanu
toxin
fragment
c
ttfc
induc
protect
lethal
challeng
ld
tetanu
toxin
moreov
gordonii
recombin
express
fima
major
subunit
protein
p
gingivali
fimbria
induc
strong
serum
igg
salivari
iga
antibodi
respons
protect
subsequ
p
gingivalisinduc
alveolar
bone
loss
germ
free
rat
two
phase
human
clinic
trial
total
subject
conduct
center
vaccin
develop
univers
maryland
school
medicin
baltimor
md
determin
time
erad
spontan
antibioticinduc
strain
gordonii
experiment
implant
nose
mouth
healthi
volunt
studi
show
antibiot
treatment
clear
implant
strain
subject
exampl
bcvsmallpox
vaccin
smallpox
destruct
diseas
record
histori
kill
crippl
disfigur
nearli
humankind
centuri
alon
million
peopl
succumb
diseas
variola
viru
caus
agent
smallpox
extrem
infecti
usual
acquir
inhal
aerosol
droplet
spread
infect
individu
variola
major
highli
virul
form
smallpox
caus
death
rate
high
diseas
number
featur
make
bidealq
agent
bioterror
tabl
although
smallpox
paramount
concern
one
neglect
potenti
orthopoxviru
pathogen
exampl
sever
recent
incurs
monkeypox
viru
human
popul
event
transpir
midwest
summer
prairi
dog
sold
pet
becam
infect
monkeypox
viru
contact
gambian
giant
rat
rodent
peopl
becam
ill
outbreak
anoth
chill
scenario
possibl
laboratori
strain
vaccinia
viru
cowpox
viru
could
genet
engin
produc
toxin
convert
potent
pathogen
fortun
orthopoxvirus
highli
relat
dna
level
eg
variola
vaccinia
make
like
vaccin
develop
would
stimul
immun
entir
group
virus
smallpox
elimin
us
subsequ
routin
prophylact
immun
discontinu
result
popul
highli
suscept
orthopoxviru
infect
howev
mass
immun
populac
advis
respons
potenti
threat
bioterror
risk
seriou
complic
vaccin
current
avail
vaccin
potenti
fatal
complic
includ
postvaccini
enceph
myopericard
progress
vaccinia
fetal
vaccinia
eczema
vaccinatum
addit
sever
less
seriou
complic
need
new
safe
smallpox
vaccin
signific
great
deal
recent
research
focus
develop
attenu
live
vaccinia
viru
mainli
use
recombin
vaccin
deliveri
system
one
viru
modifi
vaccinia
viru
ankara
mva
sever
studi
show
promis
result
abil
mva
attenu
vaccinia
induc
humor
cellmedi
immun
respons
vaccinia
heterolog
antigen
note
although
mva
genom
delet
mani
known
poxviru
immunomodulatori
gene
still
retain
abil
express
larg
number
viral
gene
product
unknown
biolog
activ
furthermor
mva
recombin
wide
develop
therapeut
vaccin
cancer
widespread
vaccin
populac
could
induc
immun
mva
viru
thu
limit
usabl
anticanc
vector
therefor
attenu
vaccinia
strain
may
use
hope
smallpox
vaccin
gener
popul
unlik
mani
virus
vv
produc
mani
virion
form
appear
infecti
molecular
detail
poxviru
assembl
differenti
thought
follow
concurr
viral
dna
replic
progeni
dna
molecul
viral
enzym
structur
protein
coalesc
form
previrion
particl
particl
acquir
two
membran
bud
intermedi
compart
endopla
ev
either
remain
associ
cell
cellassoci
envelop
viru
cev
releas
extern
medium
extracellular
envelop
viru
eev
develop
strategi
design
vaccin
smallpox
import
consid
differ
form
famili
poxviru
eev
form
viru
import
long
rang
dissemin
viru
within
host
imv
form
thought
import
transmit
infect
host
thu
suitabl
smallpox
vaccin
must
effect
form
viru
reason
sever
vv
protein
chosen
bcv
vaccin
candid
protein
associ
imv
form
viru
other
associ
eev
form
criteria
requir
candid
subunit
vv
protein
one
follow
candid
elicit
humor
cellmedi
immun
respons
antibodi
specif
protein
shown
protect
anim
model
parenter
deliv
purifi
vv
protein
elicit
protect
induct
cellmedi
respons
deliveri
gene
dna
vaccin
confer
least
partial
protect
base
criteria
sever
vaccinia
protein
chosen
promis
candid
commens
smallpox
vaccin
protein
characterist
list
tabl
dna
encod
vv
copenhagen
protein
clone
gordonii
chromosom
describ
express
protein
gordonii
test
streak
blot
western
analysi
use
antibodi
specif
protein
portion
fusion
protein
streak
blot
analysi
test
surfac
express
heterolog
protein
whole
bacteria
transfer
nitrocellulos
membran
vv
fusion
protein
express
high
level
fig
howev
express
low
shown
three
protein
contain
larg
hydrophob
region
could
interfer
process
anchor
mechan
secret
membran
gordonii
hydrophob
region
delet
gordonii
abl
effici
express
truncat
protein
fig
indic
immunoreact
vv
protein
express
gordonii
preliminari
experi
use
vv
recombin
indic
balbc
mice
inocul
either
subcutan
intranas
signific
level
serum
igg
well
salivari
igg
iga
antibodi
addit
neutral
antibodi
antibodi
capabl
inhibit
vaccinia
virusinfect
tissu
cultur
cell
present
serum
vaccin
anim
addit
studi
use
bcvvv
recombin
progress
includ
challeng
studi
assess
whether
recombin
capabl
induc
protect
immun
vaccinia
viru
infect
balbc
mous
model
vaccinia
viru
challeng
excel
system
studi
vaccin
potenti
prevent
smallpox
howev
high
degre
homolog
among
orthopoxviru
sever
addit
anim
model
use
orthopoxviru
also
provid
import
inform
smallpox
respiratori
pathogen
acquir
aerosol
viru
cowpox
viru
effici
infect
balbc
mice
aerosol
administr
use
evalu
efficaci
smallpox
vaccin
prevent
lethal
respiratori
infect
perhap
rigor
model
test
candid
smallpox
vaccin
monkeypox
model
use
rhesu
macaqu
monkeypox
orthopoxviru
infect
monkey
sometim
human
homolog
variola
major
genom
model
also
use
evalu
efficaci
vaccin
smallpox
regardless
technolog
employ
commerci
develop
vaccin
potenti
biowarfar
pathogen
challeng
number
reason
first
need
access
suffici
feder
fund
support
work
given
polit
natur
fund
process
known
long
level
fund
avail
second
difficulti
obtain
pathogen
given
recent
legisl
regul
use
third
pauciti
laboratori
avail
use
anim
challeng
experi
well
expert
conduct
experi
fourth
unansw
regulatori
question
requir
order
licens
vaccin
human
use
final
potenti
market
develop
product
must
consid
consum
pay
cost
vaccin
develop
regardless
challeng
import
goal
defens
armatur
hope
scientif
government
regulatori
agenc
abl
effect
work
togeth
make
realiti
recombin
clone
express
indic
fulllength
delet
vv
protein
pyogen
protein
alon
streak
onto
bacteri
plate
lift
onto
nitrocellulos
membran
probe
monospecif
antisera
protein
verifi
surfac
express
fusion
protein
